We then inoculated C57BL/6 mice with cells from NR1H3 or NR3C1 OE, NR2F6 KD, or control wild-type (WT) B16F10 melanoma lines; treated animals with anti–PD-1 antibodies; and evaluated them for responses to ICT. This evidence concerns the gene NR2F6 and melanoma.